German Healthtech Stock News

Deutsche Börse (XTRA:DB1) just took a meaningful step deeper into digital assets, unveiling a wide ranging strategic partnership with Kraken that links its core trading, custody, and derivatives infrastructure directly with crypto markets. See our latest analysis for Deutsche Börse. Despite the buzz around this Kraken tie up, Deutsche Börse’s €219.5 share price has logged a 5.28 percent 1 month share price return but remains slightly down year to date. Its 5 year total shareholder return of...

Thinking about whether adidas is a bargain or a value trap at today’s price? You are not alone, and this breakdown is designed to help you see what the market might be missing. Despite being up 1.0% over the last week and 2.3% over the last month, the stock is still down 31.8% year to date and 32.6% over the past year, a combination that often signals either deep value or lingering risk. Recent headlines have focused on adidas pushing harder into direct to consumer channels and refreshing...

PUMA (XTRA:PUM) has been quietly rebuilding momentum, with the stock up around 24% over the past month despite still being sharply lower year to date. That rebound raises a clear valuation question. See our latest analysis for PUMA. The recent rebound sits against a tough backdrop, with the share price still nursing a heavy year to date loss and a multi year total shareholder return deeply negative. This suggests sentiment may be stabilising rather than fully turning at this stage. If PUMA’s...

Morgan Stanley recently downgraded GEA Group AG from Equalweight to Underweight, citing concerns about the company’s ability to consistently deliver more than 5% annual organic growth between 2026 and 2028 and cutting its earnings forecasts for 2025 through 2027. The bank now projects 2026–2027 EBITA about 5% below current consensus, framing a meaningfully more cautious view of GEA’s medium-term earnings power. We’ll now examine how Morgan Stanley’s reduced growth and earnings expectations...

Key Insights Siemens Healthineers' estimated fair value is €70.47 based on 2 Stage Free Cash Flow to Equity Current...

As global markets show mixed performances, with the Nasdaq Composite and Russell 2000 Index leading gains amid hopes for a Federal Reserve interest rate cut, the technology sector continues to capture investor attention as a driver of innovation. In this environment, high growth tech stocks that demonstrate resilience and adaptability to economic shifts can be particularly appealing for those interested in companies at the forefront of global technological advancements.

As European markets show mixed performance, with the pan-European STOXX Europe 600 Index rising slightly on hopes of interest rate cuts in the U.S. and UK, investors are keenly observing economic indicators such as inflation and GDP revisions. In this context, dividend stocks become an attractive option for those seeking steady income streams amidst market fluctuations. A good dividend stock often combines a reliable payout history with strong fundamentals, making it a potential anchor in...

Deutsche Telekom (XTRA:DTE) just stepped up its AI game, unveiling a multi year collaboration with OpenAI that gives it early access to an alpha phase model and an organisation wide ChatGPT Enterprise rollout. See our latest analysis for Deutsche Telekom. The OpenAI deal lands after a choppy stretch for the stock, with the share price now at $26.86 and momentum softening in recent months despite a strong five year total shareholder return above 100 percent, suggesting the longer term thesis...

If you are wondering whether Rheinmetall is still a smart buy after its massive run up, or if the value has already been priced in, you are not alone. The stock has risen 166.6% year to date and 741.5% over 3 years, even after a recent 9.9% pullback over the last month and a 6.0% rebound in the past week. Investor sentiment has been shaped by ongoing geopolitical tensions and sustained government commitments to boost defense spending in Europe and beyond. In addition, Rheinmetall continues...

TUI recently reported the highest annual earnings in its history, supported by a 5% rise in customer bookings to 34.7 million and 4.4% revenue growth, while also planning €250 million of cost cuts in its airlines and markets division after higher expenses and Boeing delivery delays. This combination of record profitability, strong travel demand and restructuring signals how TUI is trying to protect margins while addressing operational pressures in its airline-heavy model. We’ll now examine...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights Verbio's estimated fair value is €30.71 based on 2 Stage Free Cash Flow to Equity Current share price of...

Key Insights The projected fair value for RATIONAL is €738 based on 2 Stage Free Cash Flow to Equity Current share...

Fast Finance24 Holding AG ( FRA:FF24 ) shareholders are no doubt pleased to see that the share price has bounced 26% in...

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") above 18x, you may consider Park...

In early December 2025, Vulcan Energy announced it had expanded its partnership with HOCHTIEF Group, appointing Sedgman and HOCHTIEF Infrastructure as Engineering, Procurement and Construction Management contractor for the Lionheart lithium extraction and central processing plants, alongside a planned €169 million investment that would make HOCHTIEF a cornerstone shareholder. This move deepens HOCHTIEF’s push into critical minerals and the energy transition value chain, giving it an...

Beiersdorf (XTRA:BEI) is turning heads after NIVEA Nigeria launched a N3 billion rewards campaign, mixing cash prizes, SUVs, and Real Madrid trips to fire up consumer loyalty in a tough macro backdrop. See our latest analysis for Beiersdorf. That push into Nigeria comes as Beiersdorf’s share price, now around $92.82, has seen a 1 day share price return of 1.44 percent but a much weaker year to date share price return of minus 24.96 percent, and a 1 year total shareholder return of minus 24.75...

How the OpenAI partnership ties into Nagarro’s stock story Nagarro (XTRA:NA9) becoming an OpenAI Services Partner is less about a one day headline and more about how investors should think about its future AI driven revenue mix and client stickiness. See our latest analysis for Nagarro. The OpenAI partnership has landed just as sentiment is turning. A 1 month share price return of 77.92 percent and a 3 month share price return of 57.39 percent have helped reverse earlier weakness, even though...

Delivery Hero recently confirmed that it is reviewing capital allocation and exploring options such as partnerships, asset sales, and other structural moves after large shareholders criticized its financial performance and portfolio strategy, following an approximate 53% share price drop over the past year that left the group valued at about €5.20 billion (US$6.10 billion). An important wrinkle is that investors and potential industry buyers are said to be particularly interested in...

Evotec (XTRA:EVT) just closed the sale of its Just, Evotec Biologics Toulouse plant to Sandoz and handed over an indefinite license to its continuous manufacturing tech, signaling a deliberate pivot toward a more asset-light model. See our latest analysis for Evotec. The strategic sale comes after a tough stretch, with a year to date share price return of negative 37.21 percent and a one year total shareholder return of negative 39.5 percent. This suggests sentiment is still rebuilding, even...

Over the past week, Bayer announced a slate of healthcare advances, including new clinical trials in rare kidney disease and women’s health, regulatory submissions for its imaging contrast agent gadoquatrane, and expanded U.S. clearance for its MEDRAD Centargo CT injector. Together, these moves highlight how Bayer is leaning on its pharmaceuticals and medical imaging pipeline to refresh growth drivers while addressing meaningful unmet medical needs. We’ll now explore how Bayer’s push into...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has just reported fresh progress on its ongoing share buyback, detailing another batch of repurchases that nudges the total past 2.68 million shares. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. The buyback update lands against a backdrop of steady gains, with a roughly 10 percent year to date share price return and a powerful 5 year total shareholder return of about 168 percent, signalling...

Wondering if SAP at around €210 is a bargain or a bubble? You are not alone, and this breakdown is going to tackle that value question head on. Over the last week the stock has inched up about 1.0%, but that is against a tougher backdrop of a 2.6% decline over 30 days and roughly 12.0% down year to date, after still being up more than 100% over three years. Recently, SAP has stayed in the spotlight as investors focus on its push to embed AI into its core enterprise software and its ongoing...

With a price-to-earnings (or "P/E") ratio of 14.5x Deutsche Post AG ( ETR:DHL ) may be sending bullish signals at the...